AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionBOK Financial Private Wealth, Inc.
Latest Disclosed Ownership3,714 shares
Latest Disclosed Value $ 807,758
BOK Financial Private Wealth, Inc. reports 6.59% decrease in ownership of ABBV / AbbVie Inc.

On May 12, 2026 - BOK Financial Private Wealth, Inc. filed a 13F-HR form disclosing ownership of 3,714 shares of AbbVie Inc. (US:ABBV) valued at $807,758 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 3,976 shares of AbbVie Inc.. This represents a change in shares of -6.59% during the quarter. The current value of the position is $806,421 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 3,714 -262 -6.59 808 -11.12 0.0488
2026-02-06 2025-12-31 13F ABBVIE COM 00287Y109 3,976 -119 -2.91 908 -4.22 0.0556
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 4,095 -273 -6.25 948 17.04 0.0597
2025-08-07 2025-06-30 13F ABBVIE COM 00287Y109 4,368 -395 -8.29 811 -18.76 0.0541
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 4,763 -859 -15.28 998 -0.20 0.0750
2025-02-07 2024-12-31 13F ABBVIE COM 00287Y109 5,622 -1,011 -15.24 999 -23.68 0.0726
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 6,633 188 2.92 1,310 18.46 0.0948
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 6,445 348 5.71 1,106 -0.45 0.0803
2024-05-01 2024-03-31 13F ABBVIE COM 00287Y109 6,097 352 6.13 1,110 24.72 0.0827
2024-01-30 2023-12-31 13F ABBVIE COM 00287Y109 5,745 464 8.79 890 13.09 0.0723
2023-10-13 2023-09-30 13F ABBVIE COM 00287Y109 5,281 -400 -7.04 787 2.88 0.0689
2023-08-08 2023-06-30 13F ABBVIE COM 00287Y109 5,681 0 0.00 765 -15.47 0.0624
2023-04-24 2023-03-31 13F ABBVIE COM 00287Y109 5,681 0 0.00 905 -1.42 0.0727
2023-02-02 2022-12-31 13F ABBVIE COM 00287Y109 5,681 -2,400 -29.70 918 -15.39 0.0763
2022-11-07 2022-09-30 13F/A-1 ABBVIE COM 00287Y109 8,081 2,137 35.95 1,085 19.23 0.0977
2022-11-04 2022-09-30 13F ABBVIE COM 00287Y109 3,258 -2,686 247 0.0344
2022-08-15 2022-06-30 13F ABBVIE COM 00287Y109 5,944 -8,557 -59.01 910 -61.29 0.0809
2022-05-09 2022-03-31 13F ABBVIE COM 00287Y109 14,501 2,064 16.60 2,351 39.61 0.1670
2022-02-15 2021-12-31 13F ABBVIE COM 00287Y109 12,437 5,368 75.94 1,684 120.71 0.1160
2021-11-15 2021-09-30 13F/A-1 ABBVIE COM 00287Y109 7,069 852 13.70 763 9.00 0.0608
2021-11-09 2021-09-30 13F ABBVIE COM 00287Y109 3,258 -2,959 247 0.0344
2021-08-03 2021-06-30 13F ABBVIE COM 00287Y109 6,217 1,899 43.98 700 49.89 0.0570
2021-05-12 2021-03-31 13F ABBVIE COM 00287Y109 4,318 243 5.96 467 6.86 0.0425
2021-02-01 2020-12-31 13F ABBVIE COM 00287Y109 4,075 691 20.42 437 47.64 0.0416
2020-11-06 2020-09-30 13F ABBVIE COM 00287Y109 3,384 -1,178 -25.82 296 -33.93 0.0308
2020-08-13 2020-06-30 13F ABBVIE COM 00287Y109 4,562 560 13.99 448 46.89 0.0469
2020-05-07 2020-03-31 13F ABBVIE COM 00287Y109 4,002 -414 -9.38 305 -21.99 0.0370
2020-02-05 2019-12-31 13F ABBVIE COM 00287Y109 4,416 1,158 35.54 391 58.30 0.0330
2019-11-08 2019-09-30 13F ABBVIE COM 00287Y109 3,258 3,258 247 0.0344
2019-04-30 2019-03-31 13F AbbVie COM 00287Y109 0 -2,665 -100.00 0 -100.00
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 2,665 2,665 246 0.0334
2018-08-08 2018-06-30 13F ABBVIE COM 00287Y109 0 -3,066 -100.00 0 -100.00
2018-05-09 2018-03-31 13F ABBVIE COM 00287Y109 3,066 -800 -20.69 290 -22.46 0.0478
2018-02-05 2017-12-31 13F ABBVIE COM 00287Y109 3,866 51 1.34 374 10.32 0.0593
2017-11-06 2017-09-30 13F ABBVIE COM 00287Y109 3,815 -250 -6.15 339 14.92 0.0557
2017-07-27 2017-06-30 13F ABBVIE COM 00287Y109 4,065 0 0.00 295 11.32 0.0426
2017-05-08 2017-03-31 13F ABBVIE COM 00287Y109 4,065 -250 -5.79 265 -1.85 0.0374
2017-02-08 2016-12-31 13F ABBVIE COM 00287Y109 4,315 -3,753 -46.52 270 -46.95 0.0409
2016-11-07 2016-09-30 13F ABBVIE COM 00287Y109 8,068 13 0.16 509 2.21 0.0771
2016-08-10 2016-06-30 13F ABBVIE COM 00287Y109 8,055 8,055 0.00 498 0.0792
2015-10-22 2015-09-30 13F ABBVIE COM 00287Y109 0 -3,374 -100.00 0 -100.00
2015-07-16 2015-06-30 13F ABBVIE COM 00287Y109 3,374 3,374 227 0.0378
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.